NL-OMON24236尚未招募不适用
The effect of intranasal insulin on development and behaviour of children with Phelan-McDermid syndrome.<br>Dutch: Het effect van intranasale insuline op ontwikkeling en gedrag van kinderen met het Phelan-McDermid syndroom.
niversity Medical Centre Groningen0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
On the moment of registration, the study has yet to begin. Therefore there currently are no publications concerning this study.
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age between 12 months and 18 years 0 months old at 1-1-2013;
- •2. Proven SHANK3 deletion by array-comparative genomic hybridization (array-CGH);
排除标准
- •1. A contra-indication for the use of intranasal application (e.g. anatomical obstruction);
- •2. Severe perinatal brain damage (e.g. asphyxia, haemorrhage, infection);
研究者
相似试验
已完成
2 期
The effect of intranasal insulin on development and behaviour of children with Phelan-McDermid syndromeNL-OMON37136niversitair Medisch Centrum Groningen20
进行中（未招募）
不适用
The effect of insulin nasal spray on development and behaviour of children with Phelan-McDermid syndromePhelan-McDermid syndromeEUCTR2012-002873-77-NLniversity Medical Center Groningen, Department of Genetics
招募中
2 期
Evaluating the effect of intranasal insulin administration on motor and non-motor symptoms in Parkinson’s disease patients; a randomized double-blinded placebo-controlled clinical trialIRCT20191022045196N1Shahid Beheshti University of Medical Sciences40
已完成
2 期
Safety Study of Intranasal Insulin in Type 1 Diabetes and Diabetic Peripheral NeuropathyDiabetic Peripheral NeuropathyNCT01469559University of Calgary12
已完成
2 期
Intranasal Insulin in Parkinson's DiseaseParkinson DiseaseNCT04251585HealthPartners Institute31